Evidence map›Paper›PMID 30018606›Full record

ArticleFrontiers in microbiology2018

A Novel Silver Bioactive Glass Elicits Antimicrobial Efficacy Against

Holly N Wilkinson, Sammi Iveson, Paul Catherall, Matthew J Hardman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The Skin Microbiome: Current Landscape and Future Opportunities.International journal of molecular sciences · 2023
    Review
  6. Development ofMolecular pharmaceutics · 2023
    Article
  7. How to study biofilms: technological advancements in clinical biofilm research.Frontiers in cellular and infection microbiology · 2023
    Review
  8. Article
  9. Review
  10. Gamma irradiation effectuality on the antibacterial and bioactivity behavior of multicomponent borate glasses against methicillin-resistant Staphylococcus aureus (MRSA).Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cellular benefits of single-use negative pressure wound therapy demonstrated in a novel ex vivo human skin wound model.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2021
    Article
  16. Review
  17. Article
  18. Methicillin-resistantMedChemComm · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Holly N WilkinsonSchool of Life Sciences, University of Hull, Hull, United Kingdom.
Sammi IvesonSchool of Life Sciences, University of Hull, Hull, United Kingdom.
Paul CatherallTheraglass Ltd., London, United Kingdom.
Matthew J HardmanSchool of Life Sciences, University of Hull, Hull, United Kingdom.
University of Hull · GB

Funding

Medical Research Council MR/L010267/1Medical Research Council MR/L010267/2
6 · The paper itself

Abstract

Biofilm infection is now understood to be a potent contributor to the recalcitrant nature of chronic wounds. Bacterial biofilms evade the host immune response and show increased resistance to antibiotics. Along with improvements in antibiotic stewardship, effective new anti-biofilm therapies are urgently needed for effective wound management. Previous studies have shown that bioactive glass (Bg) is able to promote healing with moderate bactericidal activity. Here we tested the antimicrobial efficacy of a novel BG incorporating silver (Bg

Indexed as

bioactive glassbiofilmPseudomonas aeruginosaStaphylococcus aureuswound healing

Identifiers

PMID30018606
PMCPMC6037725
OpenAlexW2884723897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.